U.S. Supreme Court rules against Amgen bid to revive cholesterol drug patents
By John Kruzel WASHINGTON (Reuters) -The U.S. Supreme Court on Thursday ruled against Amgen Inc in its bid to revive
2023-05-18 22:55
Drugmakers Eye $23 Billion Biotech Argenx Ahead of Key Data
European biotech firm Argenx SE is scheduled to release key drug trial data this summer. Deal-hungry Big Pharma
2023-05-17 16:15
US FTC sues to block Amgen's $27.8 billion deal for Horizon Therapeutics
By Diane Bartz and Leroy Leo WASHINGTON (Reuters) -The U.S. Federal Trade Commission said on Tuesday it has filed a
2023-05-17 05:25
FTC to block Amgen's $27.8 billion deal for Horizon Therapeutics - source
(Reuters) -The U.S. Federal Trade Commission is expected to file a lawsuit as early as Tuesday to block Amgen Inc's
2023-05-16 22:51
Amgen’s $28 Billion Horizon Buy Will Be Challenged by FTC
Amgen Inc.’s $27.8 billion deal to buy Horizon Therapeutics Plc, the largest in the biotechnology company’s history, will
2023-05-16 17:47